TAVI: Edwards CEO says Sapien 3 could hit U.S. market this year

Edwards Lifesciences CEO Michael Mussallem says the company now expects the FDA to approve its next-generation Sapien 3 replacement heart valve this year.

Edwards Lifesciences

News Well, MassDevice.com Earnings Roundup, 2015, Q1, Replacement Heart Valves

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Gqyljc